| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.597 | 15.761 | 13.908 | 12.379 | 20.244 | 35.966 | 26.547 | 39.013 | 38.684 |
| Total Income - EUR | - | 3.597 | 15.761 | 13.914 | 21.188 | 20.244 | 36.394 | 26.547 | 39.013 | 38.684 |
| Total Expenses - EUR | - | 2.688 | 13.992 | 22.504 | 12.250 | 14.306 | 13.934 | 24.375 | 32.580 | 32.438 |
| Gross Profit/Loss - EUR | - | 909 | 1.769 | -8.590 | 8.937 | 5.938 | 22.460 | 2.172 | 6.434 | 6.246 |
| Net Profit/Loss - EUR | - | 801 | 1.183 | -9.002 | 8.302 | 5.370 | 21.375 | 1.575 | 6.073 | 5.260 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Alle Gyn S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 37.998 | 28.723 | 6.689 | 6.806 | 7.125 | 7.967 | 12.106 | 60.626 |
| Current Assets | - | 926 | 139 | 1.613 | 4.955 | 1.808 | 21.188 | 1.574 | 2.857 | 1.733 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 344 | 0 |
| Receivables | - | 0 | 0 | 0 | 159 | 356 | 383 | 710 | 963 | 960 |
| Cash | - | 926 | 139 | 1.613 | 4.796 | 1.452 | 20.805 | 864 | 1.549 | 774 |
| Shareholders Funds | - | 846 | 2.014 | -7.025 | 1.413 | 6.756 | 27.982 | 301 | 6.373 | 10.620 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 81 | 36.123 | 37.865 | 10.232 | 1.858 | 331 | 9.240 | 8.590 | 51.739 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alle Gyn S.r.l.